[go: up one dir, main page]

SE8500307D0 - Nya, antiviruella medel - Google Patents

Nya, antiviruella medel

Info

Publication number
SE8500307D0
SE8500307D0 SE8500307A SE8500307A SE8500307D0 SE 8500307 D0 SE8500307 D0 SE 8500307D0 SE 8500307 A SE8500307 A SE 8500307A SE 8500307 A SE8500307 A SE 8500307A SE 8500307 D0 SE8500307 D0 SE 8500307D0
Authority
SE
Sweden
Prior art keywords
agents
antivirual
new
alkyls
chem
Prior art date
Application number
SE8500307A
Other languages
English (en)
Other versions
SE461914B (sv
SE8500307L (sv
Inventor
E J Reist
P A Sturm
Original Assignee
Stanford Res Inst Int
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Stanford Res Inst Int filed Critical Stanford Res Inst Int
Publication of SE8500307L publication Critical patent/SE8500307L/sv
Publication of SE8500307D0 publication Critical patent/SE8500307D0/sv
Publication of SE461914B publication Critical patent/SE461914B/sv

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/06—Pyrimidine radicals
    • C07H19/10—Pyrimidine radicals with the saccharide radical esterified by phosphoric or polyphosphoric acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6558—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system
    • C07F9/65586—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system at least one of the hetero rings does not contain nitrogen as ring hetero atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6561—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings
    • C07F9/65616—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings containing the ring system having three or more than three double bonds between ring members or between ring members and non-ring members, e.g. purine or analogs
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/16—Purine radicals
    • C07H19/20—Purine radicals with the saccharide radical esterified by phosphoric or polyphosphoric acids

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Virology (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Genetics & Genomics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
SE8500307A 1983-05-24 1985-01-23 Fosfonatanaloger av antiviruella nukleosidanaloger SE461914B (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US49772083A 1983-05-24 1983-05-24

Publications (3)

Publication Number Publication Date
SE8500307L SE8500307L (sv) 1985-01-23
SE8500307D0 true SE8500307D0 (sv) 1985-01-23
SE461914B SE461914B (sv) 1990-04-09

Family

ID=23978043

Family Applications (1)

Application Number Title Priority Date Filing Date
SE8500307A SE461914B (sv) 1983-05-24 1985-01-23 Fosfonatanaloger av antiviruella nukleosidanaloger

Country Status (8)

Country Link
EP (4) EP0273169A3 (sv)
JP (1) JPS60501407A (sv)
DE (1) DE3490262T1 (sv)
GB (1) GB2150570B (sv)
IT (1) IT1209921B (sv)
NL (1) NL8420134A (sv)
SE (1) SE461914B (sv)
WO (1) WO1984004748A1 (sv)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CS233665B1 (en) * 1983-01-06 1985-03-14 Antonin Holy Processing of isomere o-phosphonylmethylderivative of anantiomere racemic vicinal diene
CA1288098C (en) * 1984-08-24 1991-08-27 Richard L. Tolman 4-(guanin-9-yl)butanals and their 3-oxa, 3-thia and 2-ene derivatives having antiviral and antitumor activity
CS263951B1 (en) * 1985-04-25 1989-05-12 Antonin Holy 9-(phosponylmethoxyalkyl)adenines and method of their preparation
CS264222B1 (en) * 1986-07-18 1989-06-13 Holy Antonin N-phosphonylmethoxyalkylderivatives of bases of pytimidine and purine and method of use them
US5650510A (en) * 1986-11-18 1997-07-22 Institute Of Organic Chemistry And Biochemistry Of The Academy Of Sciences Of The Czech Republic Antiviral phosphonomethoxyalkylene purine and pyrimidine derivatives
JPH01501864A (ja) * 1987-01-20 1989-06-29 エス・アール・アイ・インターナシヨナル 抗ウイルス剤
CA1330794C (en) * 1987-03-27 1994-07-19 Phillip Frost Anti-viral compounds, dosage forms and methods
EP0338168A1 (en) * 1988-04-19 1989-10-25 Merrell Dow Pharmaceuticals Inc. Phosphonoalkylpurine derivatives
ATE98249T1 (de) * 1988-04-19 1993-12-15 Merrell Dow Pharma Phosphonoalkylpurin-derivate.
AU5165790A (en) * 1989-02-23 1990-09-26 University College London Nucleoside analogues
CA2297294C (en) * 1989-05-15 2005-11-08 Institute Of Organic Chemistry And Biochemistry Of The Academy Of Sciences Of The Czech Republic Phosphonomethoxymethylpurine/pyrimidine derivatives
US5688778A (en) * 1989-05-15 1997-11-18 Institute Of Organic Chemistry And Biochemistry Of The Academy Of Sciences Of The Czech Republic Nucleoside analogs
US5374626A (en) * 1989-09-22 1994-12-20 Farmitalia Carlo Erba 5'-alkylphosphonylnucleosides as antivirals
GB8921469D0 (en) * 1989-09-22 1989-11-08 Erba Carlo Spa 5'-alkylphosphonylnucleosides as antivirals
US5302585A (en) * 1990-04-20 1994-04-12 Institute Of Organic Chemistry And Biochemistry Of The Academy Of Sciences Of The Czech Republic Use of chiral 2-(phosphonomethoxy)propyl guanines as antiviral agents
DK0465297T3 (da) * 1990-07-04 1996-02-19 Merrell Pharma Inc 9-Purinylphosphonsyre-derivater
EP0477454A1 (en) * 1990-09-28 1992-04-01 Merrell Dow Pharmaceuticals Inc. Novel phosphonate derivatives of certain nucleosides
US5208221A (en) * 1990-11-29 1993-05-04 Bristol-Myers Squibb Company Antiviral (phosphonomethoxy) methoxy purine/pyrimidine derivatives
US5672697A (en) * 1991-02-08 1997-09-30 Gilead Sciences, Inc. Nucleoside 5'-methylene phosphonates
US5494912A (en) * 1991-06-26 1996-02-27 Merrell Pharmaceuticals Inc. 9-purinyl phosphonic acid derivitives for treating gout
AU661347B2 (en) * 1991-10-11 1995-07-20 Institute Of Organic Chemistry And Biochemistry Of The Academy Of Sciences Of The Czech Republic Antiviral acyclic phosphonomethoxyalkyl substituted, alkenyl and alkynyl purine and pyrimidine derivatives
US6057305A (en) 1992-08-05 2000-05-02 Institute Of Organic Chemistry And Biochemistry Of The Academy Of Sciences Of The Czech Republic Antiretroviral enantiomeric nucleotide analogs
RU2183213C2 (ru) * 1996-11-05 2002-06-10 ЗАО "Производственно-коммерческая ассоциация АЗТ" Модифицированные нуклеозид-5'-трифосфаты как антивирусные агенты
CN105061534A (zh) 2010-09-22 2015-11-18 艾丽奥斯生物制药有限公司 取代的核苷酸类似物
HK1203075A1 (en) 2011-12-22 2015-10-16 艾丽奥斯生物制药有限公司 Substituted phosphorothioate nucleotide analogs
EP2828277A1 (en) 2012-03-21 2015-01-28 Vertex Pharmaceuticals Incorporated Solid forms of a thiophosphoramidate nucleotide prodrug
WO2013142157A1 (en) 2012-03-22 2013-09-26 Alios Biopharma, Inc. Pharmaceutical combinations comprising a thionucleotide analog
EP3426642A4 (en) * 2016-03-09 2019-10-09 Janssen BioPharma, Inc. ACYCLIC VIRUIDE

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3238191A (en) * 1962-09-13 1966-03-01 Terrell C Myers Phosphonic acid analogs of nucleoside phosphates and method
US3524846A (en) * 1967-06-02 1970-08-18 Syntex Corp Process for the didealkylation of phosphonate esters
US3878194A (en) * 1967-07-18 1975-04-15 Syntex Inc Novel phosphorylated phosphonium ylids
US3662031A (en) * 1967-07-18 1972-05-09 Syntex Corp Phosphorylated phosphonium ylids
US3446793A (en) * 1967-10-30 1969-05-27 Syntex Corp 3'-cyclic esters of 5'-deoxy-5'-(dihydroxyphosphinylmethyl)-nucleosides
US3560478A (en) * 1968-06-14 1971-02-02 Terrell C Myers Analogues of nucleoside phosphates
CA931561A (en) * 1969-03-10 1973-08-07 Syntex Corporation Nucleoside phosphonates, phosphonic acids, phosphonic acid salts, and process for producing same
AU521577B2 (en) * 1977-02-24 1982-04-22 Wellcome Foundation Limited, The 9-hydroxyethoxymethyl guanine phosphates
US4287188A (en) * 1977-02-24 1981-09-01 Burroughs Wellcome Co. Purine derivatives
US4291024A (en) * 1978-04-10 1981-09-22 Turcotte Joseph G Cytotoxic liponucleotide analogs
EP0015584A3 (de) * 1979-03-12 1980-12-10 Kailash Kumar Dr. Prof. Gauri Neue Nukleotide, Verfahren zu ihrer Herstellung und Arzneimittel
US4347360A (en) * 1980-09-16 1982-08-31 Ens Bio Logicals Inc. Ring open nucleoside analogues
DE3045375A1 (de) * 1980-12-02 1982-07-01 Robugen Gmbh Pharmazeutische Fabrik Esslingen A.N., 7300 Esslingen Neue substituierte pyrimidin-nukleoside mit antiviraler wirkung, verfahren zu deren herstellung und daraus zubereitete arzneiformen
NZ201662A (en) * 1981-08-26 1986-07-11 Merck & Co Inc 9-(1,3-(and 2,3)-dihydroxy-1-(and 2)-propoxy-methyl)guanine derivatives and methods for their preparation

Also Published As

Publication number Publication date
GB2150570B (en) 1987-04-08
GB8500850D0 (en) 1985-02-20
SE461914B (sv) 1990-04-09
EP0273169A2 (en) 1988-07-06
GB2150570A (en) 1985-07-03
EP0274025A2 (en) 1988-07-13
EP0145739B1 (en) 1989-02-08
SE8500307L (sv) 1985-01-23
IT1209921B (it) 1989-08-30
NL8420134A (nl) 1985-04-01
JPS60501407A (ja) 1985-08-29
EP0274025A3 (en) 1990-08-29
EP0145739A1 (en) 1985-06-26
DE3490262T1 (de) 1985-11-28
EP0272446B1 (en) 1992-11-11
WO1984004748A1 (en) 1984-12-06
IT8448236A0 (it) 1984-05-22
EP0273169A3 (en) 1990-08-29
EP0272446A1 (en) 1988-06-29

Similar Documents

Publication Publication Date Title
SE8500307D0 (sv) Nya, antiviruella medel
DK0654037T3 (da) Enantiomere anti-retrovirus-nukleotidanaloger
ES8206488A1 (es) Un procedimiento para preparar compuestos de purina y piri- midina
JPS6426548A (en) Arylthioalkylphenylcarboxylic acid
ATE108452T1 (de) Puringruppen enthaltende cyclobutane.
MY113732A (en) Arylthio compounds
FI852974L (fi) Nya n-hydroxylgruppen skyddande grupper och framstaellningsfoerfarande foer 3-acylamino-1-hydroxi-2-azetidinoner.
ES8703461A1 (es) Procedimiento para preparar derivados de quinuclidina
ATE141281T1 (de) Pyrimidinnukleosidderivate mit anti-tumor aktivität ihre herstellung und verwendung
AU3292789A (en) Platinum(ii) complexes, their preparation and use as anti-tumour agents
ATE110382T1 (de) Oxetanocin.
FI861506A0 (fi) Foerfarande foer framstaellning av 1,2-ditiolan-3-pentansyra (tioktsyra).
DK129189A (da) Benzophenonderivater
GB2107315B (en) Alpha epsilon alkane diisocyanates and their use in polyurethane production
WO1991000729A3 (en) Bis-dioxopiperazines, and their use as protecting agents
ES2072304T3 (es) Pirazolinas n-sulfeniladas y n-aciladas.
EP0204148A3 (en) [1,4]Benzodioxin and [1,4]benzoxazine derivatives
AU5241490A (en) Platinum complexes and antitumor agents containing them as an active ingredient
BR8600034A (pt) Composto de eter de fenila e processo de preparacao
GR3004981T3 (sv)
TH5978A (th) อนุพันธ์ไดแซ็กคาไรด์
SE8700366D0 (sv) Medel vid lungfibros
TH4572B (th) อนุพันธ์ไดแซ็กคาไรด์
TH2671A (th) ไธโอเลน-2,4-ไดโอน-3- คาร์บอกซามีด
TH3875A (th) สารฆ่าวัชพืช n-(ฟอสฟอโนเมธิลไกลซิล) ซัลฟอนิแลมีน

Legal Events

Date Code Title Description
NUG Patent has lapsed

Ref document number: 8500307-7

Effective date: 19931210

Format of ref document f/p: F